Europe “will not capitulate” in the face of US intimidation over plans for a manufacturing waiver during the term of supplementary protection certificates (SPCs), according to European off-patent industry association Medicines for Europe.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?